These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 15728870)

  • 41. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys.
    Galler R; Marchevsky RS; Caride E; Almeida LF; Yamamura AM; Jabor AV; Motta MC; Bonaldo MC; Coutinho ES; Freire MS
    Braz J Med Biol Res; 2005 Dec; 38(12):1835-46. PubMed ID: 16302098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
    Guy B; Nougarede N; Begue S; Sanchez V; Souag N; Carre M; Chambonneau L; Morrisson DN; Shaw D; Qiao M; Dumas R; Lang J; Forrat R
    Vaccine; 2008 Oct; 26(45):5712-21. PubMed ID: 18762226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.
    Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG
    Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Susceptibility of 15 collections of Aedes albopictus from Guizhou to dengue virus oral infection].
    Shu LP; Zuo L; Zhao X; Chen AY; Wei LH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):234-7. PubMed ID: 15640856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector.
    Raja NU; Holman DH; Wang D; Raviprakash K; Juompan LY; Deitz SB; Luo M; Zhang J; Porter KR; Dong JY
    Am J Trop Med Hyg; 2007 Apr; 76(4):743-51. PubMed ID: 17426182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.
    Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility of the Sf9 insect cell line to infection with adventitious viruses.
    Zhang PF; Klutch M; Muller J; Marcus-Sekura CJ
    Biologicals; 1994 Sep; 22(3):205-13. PubMed ID: 7811453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys.
    Trindade GF; Marchevsky RS; Fillipis AM; Nogueira RM; Bonaldo MC; Acero PC; Caride E; Freire MS; Galler R
    An Acad Bras Cienc; 2008 Jun; 80(2):311-21. PubMed ID: 18506257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.
    Giel-Moloney M; Goncalvez AP; Catalan J; Lecouturier V; Girerd-Chambaz Y; Diaz F; Maldonado-Arocho F; Gomila RC; Bernard MC; Oomen R; Delagrave S; Burdin N; Kleanthous H; Jackson N; Heinrichs J; Pugachev KV
    Sci Rep; 2018 Sep; 8(1):13206. PubMed ID: 30181550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association of enhancing antibodies with seroconversion in humans receiving a dengue-2 live-virus vaccine.
    Eckels KH; Kliks SC; Dubois DR; Wahl LM; Bancroft WH
    J Immunol; 1985 Dec; 135(6):4201-3. PubMed ID: 4067313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of chimeric yellow fever 17D/dengue viral replication in ticks.
    Kazimírová M; Mantel N; Raynaud S; Slovák M; Ustaniková K; Lang J; Guy B; Barban V; Labuda M
    Vector Borne Zoonotic Dis; 2012 Nov; 12(11):979-85. PubMed ID: 22925017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
    Kinney RM; Butrapet S; Chang GJ; Tsuchiya KR; Roehrig JT; Bhamarapravati N; Gubler DJ
    Virology; 1997 Apr; 230(2):300-8. PubMed ID: 9143286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
    Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
    Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
    Johnson AJ; Guirakhoo F; Roehrig JT
    Virology; 1994 Sep; 203(2):241-9. PubMed ID: 8053148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.